K. De Boeck

15.4k total citations · 3 hit papers
250 papers, 8.9k citations indexed

About

K. De Boeck is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Physiology. According to data from OpenAlex, K. De Boeck has authored 250 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 210 papers in Pulmonary and Respiratory Medicine, 35 papers in Epidemiology and 30 papers in Physiology. Recurrent topics in K. De Boeck's work include Cystic Fibrosis Research Advances (173 papers), Neonatal Respiratory Health Research (76 papers) and Tracheal and airway disorders (55 papers). K. De Boeck is often cited by papers focused on Cystic Fibrosis Research Advances (173 papers), Neonatal Respiratory Health Research (76 papers) and Tracheal and airway disorders (55 papers). K. De Boeck collaborates with scholars based in Belgium, France and United Kingdom. K. De Boeck's co-authors include Marijke Proesmans, F. Vermeulen, Margarida D. Amaral, Michael Boyle, À. Munck, Maurits Demedts, Mieke Boon, Jane C. Davies, J.S. Elborn and Lieven Dupont and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and The Journal of Immunology.

In The Last Decade

K. De Boeck

243 papers receiving 8.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR

2015 1.2k citations J.S. Elborn, Marco Cipolli et al. profile →
Progress in therapies for cystic fibrosis

2016 307 citations K. De Boeck, Margarida D. Amaral The Lancet Respiratory Medicine profile →
Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation

2014 277 citations K. De Boeck et al. Journal of Cystic Fibrosis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. De Boeck Belgium	49	7.0k	1.4k	1.2k	1.0k	755	250	8.9k
Eitan Kerem Israel	50	7.1k 1.0×	1.8k 1.3×	1.1k 0.9×	1.4k 1.3×	1.2k 1.6×	263	10.0k
Isabelle Sermet‐Gaudelus France	49	6.8k 1.0×	1.6k 1.2×	897 0.7×	1.9k 1.8×	652 0.9×	259	10.1k
Jane C. Davies United Kingdom	49	9.0k 1.3×	2.8k 2.0×	1.7k 1.4×	1.4k 1.3×	691 0.9×	353	12.8k
Elizabeth Tullis Canada	45	6.4k 0.9×	1.1k 0.8×	649 0.5×	777 0.7×	995 1.3×	158	8.0k
Steven M. Rowe United States	56	11.3k 1.6×	2.8k 2.0×	1.6k 1.3×	1.1k 1.0×	804 1.1×	260	14.5k
Frank J. Accurso United States	57	9.9k 1.4×	2.0k 1.4×	1.3k 1.1×	1.8k 1.7×	1.0k 1.3×	191	12.5k
Moira L. Aitken United States	46	4.2k 0.6×	1.3k 0.9×	1.0k 0.8×	851 0.8×	627 0.8×	138	6.3k
Matthias Griese Germany	49	8.2k 1.2×	2.2k 1.6×	1.5k 1.2×	1.1k 1.0×	1.9k 2.5×	332	11.7k
Karen McCoy United States	38	4.7k 0.7×	1.2k 0.8×	650 0.5×	890 0.9×	554 0.7×	153	6.3k
Claire Wainwright Australia	39	6.4k 0.9×	1.1k 0.8×	703 0.6×	1.4k 1.3×	413 0.5×	185	7.9k

Countries citing papers authored by K. De Boeck

Since Specialization

Citations

This map shows the geographic impact of K. De Boeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. De Boeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. De Boeck more than expected).

Fields of papers citing papers by K. De Boeck

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. De Boeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. De Boeck. The network helps show where K. De Boeck may publish in the future.

Co-authorship network of co-authors of K. De Boeck

This figure shows the co-authorship network connecting the top 25 collaborators of K. De Boeck. A scholar is included among the top collaborators of K. De Boeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. De Boeck. K. De Boeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramalho, Anabela S., Rik Gijsbers, Ricard Farré, et al.. (2020). Phenotyping of Rare CFTR Mutations Reveals Distinct Trafficking and Functional Defects. Cells. 9(3). 754–754. 23 indexed citations

Boeck, K. De, Margarida D. Amaral, Pavel Dřevı́nek, et al.. (2020). Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders’ consensus view. Journal of Cystic Fibrosis. 19(5). 688–695. 12 indexed citations

Dřevı́nek, Pavel, Tacjana Pressler, Marco Cipolli, et al.. (2019). Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis. Journal of Cystic Fibrosis. 19(1). 99–107. 49 indexed citations

Martínez-Millana, Antonio, Jessie M. Hulst, Mieke Boon, et al.. (2018). Optimisation of children z-score calculation based on new statistical techniques. PLoS ONE. 13(12). e0208362–e0208362. 37 indexed citations

Calvo‐Lerma, Joaquim, Celia Pilar Martinez‐Jimenez, Ana Andrés, et al.. (2017). Innovative approach for self-management and social welfare of children with cystic fibrosis in Europe: development, validation and implementation of an mHealth tool (MyCyFAPP). BMJ Open. 7(3). e014931–e014931. 29 indexed citations

Calvo‐Lerma, Joaquim, Jessie M. Hulst, M. Garriga, et al.. (2017). Nutritional status, nutrient intake and use of enzyme supplements in paediatric patients with Cystic Fibrosis; a European multicentre study with reference to current guidelines. Journal of Cystic Fibrosis. 16(4). 510–518. 30 indexed citations

Boon, Mieke, Mark Jorissen, Martine Jaspers, et al.. (2016). The Influence of Nebulized Drugs on Nasal Ciliary Activity. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 29(4). 378–385. 14 indexed citations

Boon, Mieke, Stijn E. Verleden, Barbara Bosch, et al.. (2015). Morphometric Analysis of Explant Lungs in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 193(5). 516–526. 53 indexed citations

Carlon, Marianne, Johanna F. Dekkers, Monika I. Hollenhorst, et al.. (2015). rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice. American Journal of Respiratory and Critical Care Medicine. 193(3). 288–298. 57 indexed citations

10.

Boon, Mieke, Barbara Bosch, Elise Lammertyn, et al.. (2014). Quantitative evaluation of CF airways using HRCT, µCT and histology. European Respiratory Journal. 44(Suppl 58). 3447–3447. 1 indexed citations

11.

Boyle, Michael & K. De Boeck. (2013). A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect. The Lancet Respiratory Medicine. 1(2). 158–163. 164 indexed citations

12.

Aitken, Moira L., G. Bellon, K. De Boeck, et al.. (2011). Long-Term Inhaled Dry Powder Mannitol in Cystic Fibrosis: An International Randomized Study. American Journal of Respiratory and Critical Care Medicine. 185(6). 645–652. 94 indexed citations

13.

Bilton, Diana, Moira L. Aitken, Patrick A. Flume, et al.. (2011). 78 Combined data from two phase III studies of Bronchitol (inhaled dry powder mannitol) in adult cystic fibrosis (CF) patients. Journal of Cystic Fibrosis. 10. S20–S20. 2 indexed citations

14.

Sermet‐Gaudelus, Isabelle, K. De Boeck, Georges Casimir, et al.. (2010). Ataluren (PTC124) Induces Cystic Fibrosis Transmembrane Conductance Regulator Protein Expression and Activity in Children with Nonsense Mutation Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 182(10). 1262–1272. 184 indexed citations

15.

Hirche, T. O., Judy Bradley, K. De Boeck, et al.. (2010). Travelling with cystic fibrosis: Recommendations for patients and care team members. Journal of Cystic Fibrosis. 9(6). 385–399. 14 indexed citations

16.

Boon, Mieke, et al.. (2010). Exhaled Nitric Oxide: Offline Tidal Breathing Measurements Are Feasible in Children and Correlate with Online Single Breath Measurements. Pediatric Allergy Immunology and Pulmonology. 23(3). 201–206. 2 indexed citations

17.

Meyts, Isabelle, Peter W. Hellings, Greet Hens, et al.. (2006). IL-12 Contributes to Allergen-Induced Airway Inflammation in Experimental Asthma. The Journal of Immunology. 177(9). 6460–6470. 66 indexed citations

18.

Proesmans, Marijke & K. De Boeck. (2002). Evaluation of Dietary Fiber Intake in Belgian Children With Cystic Fibrosis: Is There a Link With Gastrointestinal Complaints?. Journal of Pediatric Gastroenterology and Nutrition. 35(5). 610–614. 2 indexed citations

19.

Jorissen, Mark, K. De Boeck, & Harry Cuppens. (1999). Genotype–Phenotype Correlations for the Paranasal Sinuses in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 159(5). 1412–1416. 48 indexed citations

20.

Hellinckx, Johan, et al.. (1998). Bronchodilator response in 3-6.5 years old healthy and stable asthmatic children. European Respiratory Journal. 12(2). 438–443. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact